Background illustration for clinical trials search

Fatty Liver Clinical Trials

Browse 90 Fatty Liver clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Burlington MA, East Greenwich RI, Carmel NY,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Burlington MA, East Greenwich RI, Framingham MA,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting
Active & Responsive

Siemens Biomarker Multi-modality

for
Fatty Liver, Hepatic Steatosis
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07495332

Recruiting
Active & Responsive

Fibrosis Lessens After Metabolic Surgery

for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD),
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18 - 70+

Code: NCT06374875

Recruiting
Active & Responsive

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

for
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency,
Location: Lakewood CA
Sponsor: Cure CMD

Sex: All

Age: 0+

Code: NCT01403402

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

for
Obesity, Non-Alcoholic Fatty Liver Disease,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70

Code: NCT06571474

Recruiting
Active & Responsive

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Seattle WA
Sponsor: ContextVision AB

Sex: All

Age: 18 - 70+

Code: NCT07270601

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

for
Overweight or Obesity and Elevated Liver Fat
Location: Glen Burnie MD, Miami Lakes FL, Gainesville FL,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07441252

Phase2, Recruiting
Active & Responsive

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

for
NAFLD
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 12 - 18

Code: NCT04634643

Recruiting
Active & Responsive

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Boardman OH
Sponsor: Seoul National University Hospital

Sex: All

Age: 18+

Code: NCT07192159

Recruiting
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Boston MA, Cincinnati OH, Nashville TN, Chicago IL,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

for
Non-Alcoholic Steatohepatitis,
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT03884075

Phase2, Recruiting

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

for
Non-Alcoholic Fatty Liver Disease
Location: Quebec
Sponsor: Valbiotis

Sex: All

Age: 18 - 70+

Code: NCT06704321

Recruiting

Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease

for
Non-Alcoholic Fatty Liver Disease
Location: Pasadena CA
Sponsor: Huntington Medical Research Institutes

Sex: All

Age: 18+

Code: NCT00941642

Recruiting

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

for
Diabetes Mellitus, Type 2, PreDiabetes, Insulin Resistance,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 35 - 65

Code: NCT05165706

Recruiting

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

for
Non-Alcoholic Fatty Liver Disease
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 65

Code: NCT05332613

Recruiting

The Olmsted NAFLD Epidemiology Study (TONES)

for
Non-Alcoholic Fatty Liver Disease,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04365855

Recruiting

Fatty Liver Patient Registry

for
Non-Alcoholic Fatty Liver Disease
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02298439

Recruiting